Hims & Hers Health Inc (NYSE: HIMS) stock fell -3.11% on Friday to $7.47 against a previous-day closing price of $7.71. With 2.35 million shares changed hands, the volume of the stock remained lighter than its average volume of 2.41 million shares. During the session, the Household & Personal Products company that operates in wider Consumer Defensive sector, reached to the highest price of $7.78 whereas the lowest price it dropped to was $7.40. The 52-week range on HIMS shows that it touched its highest point at $12.34 and its lowest point at $5.61 during that stretch. It currently has a 1-year price target of $10.39. Beta for the stock currently stands at 0.66.

Top 5 EV Tech Stocks to Buy for 2023

The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".

Click Here to Download the FREE Report.


Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of HIMS was up-trending over the past week, with a rise of 9.69%, but this was up by 23.47% over a month. Three-month performance surged to 6.71% while six-month performance fell -23.54%. The stock gained 29.24% in the past year, while it has gained 16.54% so far this year. A look at the trailing 12-month EPS for HIMS yields -0.17 with Next year EPS estimates of -0.04. For the next quarter, that number is -0.02. This implies an EPS growth rate of 60.02% for this year and 69.91% for next year.

Float and Shares Shorts:

At present, 200.05 million HIMS shares are outstanding with a float of 135.77 million shares on hand for trading. On Oct 30, 2023, short shares totaled 16.96 million, which was 8.00% higher than short shares on Sep 28, 2023. In addition to Mr. Andrew Dudum as the firm’s Co-Founder, Chairman & CEO, Mr. Yemi Okupe serves as its Chief Financial Officer.

Institutional Ownership:

Through their ownership of 63.05% of HIMS’s outstanding shares, institutional investors have majority control over the company.

Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for HIMS since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential. With HIMS analysts setting a high price target of $15.00 and a low target of $7.00, the average target price over the next 12 months is $10.39. Based on these targets, HIMS could surge 100.8% to reach the target high and fall by -6.29% to reach the target low. Reaching the average price target will result in a growth of 39.09% from current levels.

Summary of Insider Activity:

Insiders traded HIMS stock several times over the past three months with 9 Buys and 17 Sells. In these transactions, 365,988 shares were bought while 269,526 shares were sold. The number of buy transactions has increased to 79 while that of sell transactions has risen to 108 over the past year. The total number of shares bought during that period was 4,998,374 while 14,521,108 shares were sold.

Leave a Reply

Your email address will not be published. Required fields are marked *